Table 2.
Risk of bias in included trials
| First author (yr) [ref] | Random sequence generation | Allocation concealment | Patient and practitioner blinding | Assessor blinding | Reporting drop-out or withdrawal | Intention-to-treat analysis | Selective outcome reporting | Other potential bias |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Oh (2010) [11] | L | U | L | L | L | H | L | U |
| Kim (2009) [12] | U | U | L | U | U | U | U | H |
| Kim (2012) [13] | L | U | L | U | L | L | U | U |
| Wiklund (1999) [14] | U | U | L | U | L | L | L | U |
L, low risk of bias; U, unclear; H, high risk of bias.